Transcat, Inc. (TRNS) Tops Q3 EPS by 8c

Transcat, Inc. (NASDAQ: TRNS) reported Q3 EPS of $0.35, $0.08 better than the analyst estimate of $0.27. Revenue for the quarter came in at $57.4 million versus the consensus estimate of $56.6 million.

For earnings history and earnings-related data on Transcat, Inc. (TRNS) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c